The approval represents a win in what’s been a difficult regulatory environment of late for vaccine makers, and could boost uptake of a shot that’s posted flattening sales after an initially strong ...

GSK Plc agreed to buy 35Pharma Inc., a biotech with an early-stage drug for pulmonary hypertension, as the UK pharma giant boosts its pipeline of promising experimental therapies. GSK will buy the ...

GSK struck a $950 million deal to buy Canada’s 35Pharma, a biopharmaceutical company developing cardiopulmonary treatments, as the U.K. drugmaker seeks to bolster its exposure to diseases linked to ...

Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK plc whereby GSK will obtain exclusive worldwide rights to develop, manufacture and commercialize two of ...

GSK and Bora Pharmaceuticals agreed to renew a five-year manufacturing partnership. The deal extends a 2020 agreement, under which Bora manufactures more than 20 commercial products for GSK at its ...

By integrating GSK's deep knowledge of neurodegeneration, translational science and drug discovery with JAX-NYSCF's pioneering stem cell technology and expertise, access to relevant patient cohorts, ...

There are lots of new regulations sweeping into F1 in 2026, and here at GPFans, we've got you covered if you're a little confused about them! For the first time since 2014, both aerodynamic car design ...

Race strategy in Formula E had a big shake up last season, when PIT BOOST (in partnership with Fortescue Zero) was introduced across all double-header race weekends. Previously, cars had been involved ...